| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |